Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure among Evacuees from Wuhan, China, 2020.
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
- المؤلفون: Hallowell, Benjamin D1 (AUTHOR); Carlson, Christina M (AUTHOR); Jacobs, Jesica R (AUTHOR); Pomeroy, Mary (AUTHOR); Steinberg, Jonathan (AUTHOR); Tenforde, Mark (AUTHOR); McDonald, Emily (AUTHOR); Foster, Loretta (AUTHOR); Feldstein, Leora R (AUTHOR); Rolfes, Melissa A (AUTHOR); Haynes, Amber (AUTHOR); Abedi, Glen R (AUTHOR); Odongo, George S (AUTHOR); Saruwatari, Kim (AUTHOR); Rider, Errin C (AUTHOR); Douville, Gina (AUTHOR); Bhakta, Neenaben (AUTHOR); Maniatis, Panagiotis (AUTHOR); Lindstrom, Stephen (AUTHOR); Thornburg, Natalie J (AUTHOR)
- المصدر:
Emerging Infectious Diseases. Sep2020, Vol. 26 Issue 9, p1998-2004. 7p.
- الموضوع:
- معلومة اضافية
- الموضوع:
- نبذة مختصرة :
To determine prevalence of, seroprevalence of, and potential exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among a cohort of evacuees returning to the United States from Wuhan, China, in January 2020, we conducted a cross-sectional study of quarantined evacuees from 1 repatriation flight. Overall, 193 of 195 evacuees completed exposure surveys and submitted upper respiratory or serum specimens or both at arrival in the United States. Nearly all evacuees had taken preventive measures to limit potential exposure while in Wuhan, and none had detectable SARS-CoV-2 in upper respiratory tract specimens, suggesting the absence of asymptomatic respiratory shedding among this group at the time of testing. Evidence of antibodies to SARS-CoV-2 was detected in 1 evacuee, who reported experiencing no symptoms or high-risk exposures in the previous 2 months. These findings demonstrated that this group of evacuees posed a low risk of introducing SARS-CoV-2 to the United States. [ABSTRACT FROM AUTHOR]
No Comments.